Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Ernesto Sparrelid to Middle Aged

This is a "connection" page, showing publications Ernesto Sparrelid has written about Middle Aged.

 
Connection Strength
 
 
 
0.886
 
  1. Sparrelid E, Valls-Duran C, Danielsson O, Sun W, Engstrand J, Gilg S, Ghorbani P, Sturesson C, Jansson A. Ciliated hepatic foregut cysts: a large retrospective single-centre series. Scand J Gastroenterol. 2025 Apr; 60(4):355-360.
    View in: PubMed
    Score: 0.054
  2. Wang Q, Brismar TB, Bj?rk D, Baubeta E, Lindell G, Bj?rnsson B, Sparrelid E. Development and External Validation of a Combined Clinical-Radiomic Model for Predicting Insufficient Hypertrophy of the Future Liver Remnant following Portal Vein Embolization. Ann Surg Oncol. 2025 Mar; 32(3):1795-1807.
    View in: PubMed
    Score: 0.053
  3. Reese T, Gilg S, B?cker J, Wagner KC, Vali M, Engstrand J, Kern A, Sturesson C, Oldhafer KJ, Sparrelid E. Impact of the future liver remnant volume before major hepatectomy. Eur J Surg Oncol. 2024 Nov; 50(11):108660.
    View in: PubMed
    Score: 0.052
  4. Perri G, Siriwardena AK, Gilg S, Sparrelid E. European fellowship training opportunities for hepato-pancreato-biliary surgery: an international survey of fellows and program directors. HPB (Oxford). 2024 04; 26(4):503-511.
    View in: PubMed
    Score: 0.050
  5. Sparrelid E, Thorsen T, Sauter C, Jorns C, St?l P, Nordin A, de Boer MT, Buis C, Yaqub S, Schultz NA, Larsen PN, Sallinen V, Line PD, Gilg S. Liver transplantation in patients with post-hepatectomy liver failure - A Northern European multicenter cohort study. HPB (Oxford). 2022 07; 24(7):1138-1144.
    View in: PubMed
    Score: 0.043
  6. Villard C, Habib M, Nordenvall C, Nilsson PJ, Jorns C, Sparrelid E. Conversion therapy in patients with colorectal liver metastases. Eur J Surg Oncol. 2021 08; 47(8):2038-2045.
    View in: PubMed
    Score: 0.041
  7. Bj?rnsson B, Hasselgren K, R?sok B, Larsen PN, Urdzik J, Schultz NA, Carling U, Fallentin E, Gilg S, Sandstr?m P, Lindell G, Sparrelid E. Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort study. Int J Surg. 2020 Mar; 75:60-65.
    View in: PubMed
    Score: 0.038
  8. Jansson H, Cornillet M, Bj?rkstr?m NK, Sturesson C, Sparrelid E. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort. Eur J Surg Oncol. 2020 05; 46(5):804-810.
    View in: PubMed
    Score: 0.038
  9. Sparrelid E, Johansson H, Gilg S, Nowak G, Ellis E, Isaksson B. Serial Assessment of Growth Factors Associated with Liver Regeneration in Patients Operated with Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. Eur Surg Res. 2018; 59(1-2):72-82.
    View in: PubMed
    Score: 0.034
  10. Sparrelid E, Jonas E, Tzortzakakis A, Dahl?n U, Murquist G, Brismar T, Axelsson R, Isaksson B. Dynamic Evaluation of Liver Volume and Function in Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. J Gastrointest Surg. 2017 06; 21(6):967-974.
    View in: PubMed
    Score: 0.031
  11. Sparrelid E, Gilg S, Brismar TB, Lundell L, Isaksson B. Rescue ALPPS is efficient and safe after failed portal vein occlusion in patients with colorectal liver metastases. Langenbecks Arch Surg. 2017 Feb; 402(1):69-75.
    View in: PubMed
    Score: 0.030
  12. Bartholom? WC, Gilg S, Lundberg P, Larsen PN, Sallinen V, Sternby Eilard M, Urdzik J, Lindell G, Brismar TB, Fallentin E, Ovissi A, Socratous A, Bjerner T, Kollbeck S, Tellman J, Holmquist F, Dahlstr?m N, Woisetschl?ger M, Bj?rnsson B, Sparrelid E, Sandstr?m P. Magnetic resonance-derived hepatic uptake index improves the identification of patients at risk of severe post-hepatectomy liver failure. Br J Surg. 2025 Apr 30; 112(5).
    View in: PubMed
    Score: 0.014
  13. Dall'Olio T, Perri G, Reese T, Sparrelid E, Gilg S. Implementation of a robotic hepato-pancreato-biliary surgery program: a swedish referral center's experience. J Robot Surg. 2025 Mar 06; 19(1):101.
    View in: PubMed
    Score: 0.014
  14. Bonsdorff A, Kjeseth T, Kirkeg?rd J, de Ponthaud C, Ghorbani P, Wennerblom J, Williamson C, Acher AW, Thillai M, Tarvainen T, Helanter? I, Uutela A, Sir?n J, Kokkola A, Sahakyan M, Kleive D, Hagen R, Lund A, Nielsen MF, Vaillant JC, Fristedt R, Bi?rserud C, Bratlie SO, Tingstedt B, Labori KJ, Gaujoux S, Wigmore SJ, Hallet J, Sparrelid E, Sallinen V. International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model. Br J Surg. 2025 Mar 04; 112(3).
    View in: PubMed
    Score: 0.014
  15. Rompen IF, Stoop TF, van Roessel S, van Veldhuisen E, Janssen QP, Alseidi A, Balduzzi A, Balzano G, Berrevoet F, Bonds M, Busch OR, Butturini G, Javed AA, Del Chiaro M, Conlon KC, Falconi M, Frigerio I, Fusai GK, Gagni?re J, Griffin O, Hackert T, Sparrelid E, Halimi A, Labori KJ, Malleo G, Marino MV, Mortensen MB, Nikov A, Lesurtel M, Keck T, Kleeff J, Pand? R, Pfeiffer P, Pietrasz D, Roberts KJ, Sa Cunha A, Salvia R, Strobel O, Tarvainen T, van Laarhoven HWM, Groot Koerkamp B, Loos M, Michalski CW, Besselink MG, Hank T. Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX. Ann Surg. 2025 May 01; 281(5):852-860.
    View in: PubMed
    Score: 0.013
  16. Oba A, Tanaka K, Inoue Y, Valente R, Rangelova E, Arnelo U, Ono Y, Sato T, Torphy RJ, Ito H, L?hr M, Takahashi Y, Schulick RD, Saiura A, Sparrelid E, Del Chiaro M. Pancreatectomies with vein resection: Two large institutions' experience of East and West. Pancreatology. 2025 Mar; 25(2):250-257.
    View in: PubMed
    Score: 0.013
  17. Rangelova E, Stoop TF, van Ramshorst TME, Ali M, van Bodegraven EA, Javed AA, Hashimoto D, Steyerberg E, Banerjee A, Jain A, Sauvanet A, Serrablo A, Giani A, Giardino A, Zerbi A, Arshad A, Wijma AG, Coratti A, Zironda A, Socratous A, Rojas A, Halimi A, Ejaz A, Oba A, Patel BY, Bj?rnsson B, Reames BN, Tingstedt B, Goh BKP, Pay?-Llorente C, Del Pozo CD, Gonz?lez-Ab?s C, Medin C, van Eijck CHJ, de Ponthaud C, Takishita C, Schwabl C, M?nsson C, Ricci C, Thiels CA, Douchi D, Hughes DL, Kilburn D, Flanking D, Kleive D, Silva DS, Edil BH, Pando E, Moltzer E, Kauffman EF, Warren E, Bozkurt E, Sparrelid E, Thoma E, Verkolf E, Ausania F, Giannone F, H?ttner FJ, Burdio F, Souche FR, Berrevoet F, Daams F, Motoi F, Saliba G, Kazemier G, Roeyen G, Nappo G, Butturini G, Ferrari G, Kito Fusai G, Honda G, Sergeant G, Karteszi H, Takami H, Suto H, Matsumoto I, Mora-Oliver I, Frigerio I, Fabre JM, Chen J, Sham JG, Davide J, Urdzik J, de Martino J, Nielsen K, Okano K, Kamei K, Okada K, Tanaka K, Labori KJ, Goodsell KE, Alberici L, Webber L, Kirkov L, de Franco L, Miyashita M, Maglione M, Gramellini M, Ramera M, Amaral MJ, Ramaekers M, Truty MJ, van Dam MA, Stommel MWJ, Petrikowski M, Imamura M, Hayashi M, D'Hondt M, Brunner M, Hogg ME, Zhang C, Su?rez-Mu?oz M?, Luyer MD, Unno M, Mizuma M, Janot M, Sahakyan MA, Jamieson NB, Busch OR, Bilge O, Belyaev O, Franklin O, S?nchez-Vel?zquez P, Pessaux P, Holka PS, Ghorbani P, Casadei R, Sartoris R, Schulick RD, Gr?tzmann R, Sutcliffe R, Mata R, Patel RB, Takahashi R, Rodriguez Franco S, Cab?s SS, Hirano S, Gaujoux S, Festen S, Kozono S, Maithel SK, Chai SM, Yamaki S, van Laarhoven S, Mieog JSD, Murakami T, Codjia T, Sumiyoshi T, Karsten TM, Nakamura T, Sugawara T, Boggi U, Hartman V, de Meijer VE, Bartholom? W, Kwon W, Koh YX, Cho Y, Takeyama Y, Inoue Y, Nagakawa Y, Kawamoto Y, Ome Y, Soonawalla Z, Uemura K, Wolfgang CL, Jang JY, Padbury R, Satoi S, Messersmith W, Wilmink JW, Abu Hilal M, Besselink MG, Del Chiaro M. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Ann Oncol. 2025 May; 36(5):529-542.
    View in: PubMed
    Score: 0.013
  18. Andel PCM, van Goor IWJM, Augustinus S, Berrevoet F, Besselink MG, Bhojwani R, Boggi U, Bouwense SAW, Cirkel GA, van Dam JL, Djanani A, Dorcaratto D, Dreyer S, den Dulk M, Frigerio I, Ghorbani P, Goetz MR, Groot Koerkamp B, Gryspeerdt F, Hidalgo Salinas C, Intven M, Izbicki JR, Jorba Martin R, Kauffmann EF, Klug R, Liem MSL, Luyer MDP, Maglione M, Martin-Perez E, Meerdink M, de Meijer VE, Nieuwenhuijs VB, Nikov A, Nunes V, Pando E, Radenkovic D, Roeyen G, Sanchez-Bueno F, Serrablo A, Sparrelid E, Tepetes K, Thakkar RG, Tzimas GN, Verdonk RC, Ten Winkel M, Zerbi A, Groot VP, Molenaar IQ, Daamen LA, van Santvoort HC. Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma. JAMA Surg. 2025 Jan 01; 160(1):74-84.
    View in: PubMed
    Score: 0.013
  19. Radkiewicz C, Ludvigsson JF, Sparrelid E, Emilsson L. Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study. Eur J Cancer. 2025 Jan; 214:115140.
    View in: PubMed
    Score: 0.013
  20. Olthof PB, Bouwense SAW, Bednarsch J, Dewulf M, Kazemier G, Maithel S, Jarnagin WR, Aldrighetti L, Roberts KJ, Troisi RI, Malago MM, Lang H, Alikhanov R, Ruzzenente A, Malik H, Charco R, Sparrelid E, Pratschke J, Cescon M, Nadalin S, Hagendoorn J, Schadde E, Hoogwater FJH, Schnitzbauer AA, Topal B, Lodge P, Olde Damink SWM, Neumann UP, Groot Koerkamp B. Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort. Ann Surg Oncol. 2025 Mar; 32(3):1762-1768.
    View in: PubMed
    Score: 0.013
  21. Villard C, Widman L, Sparrelid E, Bergquist A, Hagstr?m H. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol. 2024 11; 59(11):1249-1251.
    View in: PubMed
    Score: 0.013
  22. Larsson P, Swartling O, Cheraghi D, Khawaja A, Soreide K, Sparrelid E, Ghorbani P. Assessment of Outcomes by Intention-to-Treat Comparison for Locally Advanced Pancreatic Cancer: A Population-Derived Cohort Study. Ann Surg Oncol. 2025 Jan; 32(1):508-516.
    View in: PubMed
    Score: 0.013
  23. Coppola A, La Vaccara V, Farolfi T, Asbun HJ, Boggi U, Conlon K, Edwin B, Ferrone C, Jonas E, Kokudo N, Perez EM, Satoi S, Sparrelid E, Stauffer J, Zerbi A, Takemura N, Lai Q, Almerey T, Bernon M, Cammarata R, Djoumi Y, Gallagher T, Ghorbani P, Ginesini M, Hashimoto D, Kauffmann EF, Kleive D, Llu?s N, Gonz?lez RM, Napoli N, Nappo G, Nebbia M, Ricchitelli S, Sahakyan MA, Yamamoto T, Coppola R, Caputo D. Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria. Int J Surg. 2024 Oct 01; 110(10):6092-6099.
    View in: PubMed
    Score: 0.013
  24. Kuemmerli C, Sijberden JP, Cipriani F, Osei-Bordom D, Aghayan D, Lanari J, de Meyere C, Cacciaguerra AB, Rotellar F, Fuks D, Liu R, Besselink MG, Zimmitti G, Ruzzenente A, di Benedetto F, Succandy I, Efanov M, Memeo R, Jovine E, Vrochides D, Dagher I, Croner R, Lopez-Ben S, Geller D, Ahmad J, Gallagher T, White S, Alseidi A, Goh BKP, Sparrelid E, Ratti F, Marudanayagam R, Fretland ?A, Vivarelli M, D'Hondt M, Cillo U, Edwin B, Sutcliffe RP, Aldrighetti LA, Hilal MA. Is prolonged operative time associated with postoperative complications in liver surgery? An international multicentre cohort study of 5424 patients. Surg Endosc. 2024 Dec; 38(12):7118-7130.
    View in: PubMed
    Score: 0.013
  25. Nilsson T, Rasinski P, Smedby ?, Af Bur?n S, Sparrelid E, L?hr JM, Tran TA, Blomgren A, Tzortzakakis A, Axelsson R, Holstensson M. Acquisition Duration Optimization Using Visual Grading Regression in [68Ga]FAPI-46 PET Imaging of Oncologic Patients. J Nucl Med Technol. 2024 Sep 05; 52(3):221-228.
    View in: PubMed
    Score: 0.013
  26. van Bodegraven EA, van Ramshorst TME, Bratlie SO, Kokkola A, Sparrelid E, Bj?rnsson B, Kleive D, Burgdorf SK, Dokmak S, Groot Koerkamp B, Cab?s SS, Molenaar IQ, Boggi U, Busch OR, Petric M, Roeyen G, Hackert T, Lips DJ, D'Hondt M, Coolsen MME, Ferrari G, Tingstedt B, Serrablo A, Gaujoux S, Ramera M, Khatkov I, Ausania F, Souche R, Festen S, Berrevoet F, Keck T, Sutcliffe RP, Pando E, de Wilde RF, Aussilhou B, Krohn PS, Edwin B, Sandstr?m P, Gilg S, Sepp?nen H, Vilhav C, Abu Hilal M, Besselink MG. Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry a retrospective cohort study. Int J Surg. 2024 Jun 01; 110(6):3554-3561.
    View in: PubMed
    Score: 0.013
  27. Uijterwijk BA, Lemmers DH, Fusai GK, Zerbi A, Salvia R, Sparrelid E, White S, Bj?rnsson B, Mavroeidis VK, Roberts KJ, Mazzola M, Cab?s SS, Soonawalla Z, Korkolis D, Serradilla M, Pessaux P, Luyer M, Mowbray N, Ielpo B, Mazzotta A, Kleeff J, Boggi U, Mu?oz MAS, Goh BKP, Andreotti E, Wilmink H, Ghidini M, Zaniboni A, Verbeke C, Adsay V, Bianchi D, Besselink MG, Abu Hilal M. Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review. Ann Surg Oncol. 2024 Jul; 31(7):4654-4664.
    View in: PubMed
    Score: 0.013
  28. Sijberden JP, Hoogteijling TJ, Aghayan D, Ratti F, Tan EK, Morrison-Jones V, Lanari J, Haentjens L, Wei K, Tzedakis S, Martinie J, Osei Bordom D, Zimmitti G, Crespo K, Magistri P, Russolillo N, Conci S, G?rgec B, Benedetti Cacciaguerra A, D'Souza D, Zozaya G, Caula C, Geller D, Robles Campos R, Croner R, Rehman S, Jovine E, Efanov M, Alseidi A, Memeo R, Dagher I, Giuliante F, Sparrelid E, Ahmad J, Gallagher T, Schmelzle M, Swijnenburg RJ, Fretland ?A, Cipriani F, Koh YX, White S, Lopez Ben S, Rotellar F, Serrano PE, Vivarelli M, Ruzzenente A, Ferrero A, Di Benedetto F, Besselink MG, Sucandy I, Sutcliffe RP, Vrochides D, Fuks D, Liu R, D'Hondt M, Cillo U, Primrose JN, Goh BKP, Aldrighetti LA, Edwin B, Abu Hilal M. Robotic Versus Laparoscopic Liver Resection in Various Settings: An International Multicenter Propensity Score Matched Study of 10.075 Patients. Ann Surg. 2024 Jul 01; 280(1):108-117.
    View in: PubMed
    Score: 0.013
  29. Olthof PB, Erdmann JI, Alikhanov R, Charco R, Guglielmi A, Hagendoorn J, Hakeem A, Hoogwater FJH, Jarnagin WR, Kazemier G, Lang H, Maithel SK, Malago M, Malik HZ, Nadalin S, Neumann U, Olde Damink SWM, Pratschke J, Ratti F, Ravaioli M, Roberts KJ, Schadde E, Schnitzbauer AA, Sparrelid E, Topal B, Troisi RI, Groot Koerkamp B. Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible. Ann Surg Oncol. 2024 Jul; 31(7):4405-4412.
    View in: PubMed
    Score: 0.013
  30. Fr?berg K, Halimi A, Vujasinovic M, Caballero-Corbalan J, Arnelo U, Sparrelid E, Korsgren O, L?hr JM, Lundgren T, Ghorbani P. Outcome after total pancreatectomy with islet autotransplantation: A European single-center study. Scand J Surg. 2024 Jun; 113(2):80-87.
    View in: PubMed
    Score: 0.012
  31. Swartling O, Evans M, Larsson P, Gilg S, Holmberg M, Klevebro F, L?hr M, Sparrelid E, Ghorbani P. Risk factors for acute kidney injury after pancreatoduodenectomy, and association with postoperative complications and death. Pancreatology. 2023 Mar; 23(2):227-233.
    View in: PubMed
    Score: 0.012
  32. Villard C, Abdelrafee A, Habib M, Ndegwa N, Jorns C, Sparrelid E, Allard MA, Adam R. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model. Eur J Surg Oncol. 2022 Dec; 48(12):2432-2439.
    View in: PubMed
    Score: 0.011
  33. Nikolic S, Ghorbani P, Pozzi Mucelli R, Ghazi S, Baldaque-Silva F, Del Chiaro M, Sparrelid E, Verbeke CS, L?hr JM, Vujasinovic M. Surgery in Autoimmune Pancreatitis. Dig Surg. 2022; 39(1):32-41.
    View in: PubMed
    Score: 0.011
  34. Hasselgren K, R?sok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, Bj?rnbeth BA, Isaksson B, Larsson AL, Rizell M, Bj?rnsson B, Sandstr?m P. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021 03 01; 273(3):442-448.
    View in: PubMed
    Score: 0.010
  35. Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, Lang H, Guglielmi A, van Gulik TM. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma. Ann Surg Oncol. 2020 Jul; 27(7):2311-2318.
    View in: PubMed
    Score: 0.010
  36. Cornillet M, Jansson H, Schaffer M, Hertwig L, Berglin L, Zimmer CL, Johansson H, Ellis E, Isaksson B, Gonzalez-Galarza FF, Middleton D, Malmberg KJ, Sparrelid E, Bj?rkstr?m NK. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer. Gastroenterology. 2019 10; 157(4):1067-1080.e9.
    View in: PubMed
    Score: 0.009
  37. Sparrelid E, H?gglund H, Remberger M, Ringd?n O, L?nnqvist B, Ljungman P, Andersson J. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant. 1998 Oct; 22(8):795-800.
    View in: PubMed
    Score: 0.009
  38. Sandstr?m P, R?sok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, Schultz NA, Bj?rnbeth BA, Isaksson B, Rizell M, Bj?rnsson B. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial). Ann Surg. 2018 05; 267(5):833-840.
    View in: PubMed
    Score: 0.008
  39. Sanjeevi S, Sparrelid E, Gilg S, Jonas E, Isaksson B. High incidence of biliary stricture after associating liver partition and portal vein ligation for staged hepatectomy. ANZ J Surg. 2018 Jul-Aug; 88(7-8):760-764.
    View in: PubMed
    Score: 0.008
  40. Olthof PB, Tomassini F, Huespe PE, Truant S, Pruvot FR, Troisi RI, Castro C, Schadde E, Axelsson R, Sparrelid E, Bennink RJ, Adam R, van Gulik TM, de Santibanes E. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function. Surgery. 2017 10; 162(4):775-783.
    View in: PubMed
    Score: 0.008
  41. Sparrelid E, Ljungman P, Ekel?f-Andstr?m E, Aschan J, Ringd?n O, Winiarski J, W?hlin B, Andersson J. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant. 1997 May; 19(9):905-8.
    View in: PubMed
    Score: 0.008
  42. Gilg S, Sparrelid E, Isaksson B, Lundell L, Nowak G, Str?mberg C. Mortality-related risk factors and long-term survival after 4460 liver resections in Sweden-a population-based study. Langenbecks Arch Surg. 2017 Feb; 402(1):105-113.
    View in: PubMed
    Score: 0.008
  43. Bj?rnsson B, Sparrelid E, Hasselgren K, Gasslander T, Isaksson B, Sandstr?m P. Associating Liver Partition and Portal Vein Ligation for Primary Hepatobiliary Malignancies and Non-Colorectal Liver Metastases. Scand J Surg. 2016 Sep; 105(3):158-62.
    View in: PubMed
    Score: 0.007
  44. Bj?rnsson B, Sparrelid E, R?sok B, Pomianowska E, Hasselgren K, Gasslander T, Bj?rnbeth BA, Isaksson B, Sandstr?m P. Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases--Intermediate oncological results. Eur J Surg Oncol. 2016 Apr; 42(4):531-7.
    View in: PubMed
    Score: 0.007
  45. Sparrelid E, H?gglund H, Remberger M, Ljungman P, Malmborg AS, Winiarski J, Andersson J, Ringd?n O. Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation. Transplant Proc. 1995 Dec; 27(6):3530.
    View in: PubMed
    Score: 0.007
  46. R?sok BI, Bj?rnsson B, Sparrelid E, Hasselgren K, Pomianowska E, Gasslander T, Bj?rnbeth BA, Isaksson B, Sandstr?m P. Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure. Surgery. 2016 May; 159(5):1279-86.
    View in: PubMed
    Score: 0.007
  47. Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB (Oxford). 2015 Jun; 17(6):529-35.
    View in: PubMed
    Score: 0.007
  48. Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis. 2014 Feb; 16(1):106-14.
    View in: PubMed
    Score: 0.006
  49. Omar H, H?gglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringd?n O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Transpl Infect Dis. 2009 Oct; 11(5):393-9.
    View in: PubMed
    Score: 0.005
  50. Ringd?n O, S?derdahl G, Mattsson J, Uzunel M, Remberger M, Hentschke P, H?gglund H, Sparrelid E, Elmhorn-Rosenborg A, Duraj F, Zetterquist H, Ericzon BG. Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer. Transplantation. 2000 May 27; 69(10):2043-8.
    View in: PubMed
    Score: 0.002
  51. Ljungman P, Aschan J, Lewensohn-Fuchs I, Carlens S, Larsson K, L?nnqvist B, Mattsson J, Sparrelid E, Winiarski J, Ringd?n O. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients. Transplantation. 1998 Nov 27; 66(10):1330-4.
    View in: PubMed
    Score: 0.002
  52. Ringd?n O, Remberger M, Carlens S, Hagglund H, Mattsson J, Aschan J, L?nnqvist B, Klaesson S, Winiarski J, Dalianis T, Olerup O, Sparrelid E, Elmhorn-Rosenborg A, Svahn BM, Ljungman P. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies. Transplantation. 1998 Sep 15; 66(5):620-5.
    View in: PubMed
    Score: 0.002
  53. H?gglund H, Ringd?n O, Remberger M, L?nnqvist B, Sparrelid E, Tammik L, Kumlien G. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow. Bone Marrow Transplant. 1998 Jul; 22(2):131-6.
    View in: PubMed
    Score: 0.002
  54. Ringd?n O, Remberger M, Mattsson J, Aschan J, Carlens S, H?gglund H, L?nnqvist B, Sparrelid E, Ljungman P. Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age. Bone Marrow Transplant. 1998 Jan; 21(1):43-9.
    View in: PubMed
    Score: 0.002
  55. Ringd?n O, Remberger M, Mattsson J, Aschan J, H?gglund H, Carlens S, L?nnqvist B, Sparrelid E, Ljungman P. Transplantation with unrelated bone marrow in leukemic patients above 40 years of age. Transplant Proc. 1997 Nov; 29(7):3145-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)